Modified Constraint Induced Movement Therapy for Cerebral Palsy

This trial aims to explore the costs of running a special day camp for children with hemiparesis (weakness on one side of the body) due to conditions like cerebral palsy or brain injury. The camp includes a week of modified constraint-induced movement therapy, where the stronger arm is restrained to encourage movement in the weaker arm, followed by a week of bimanual therapy, which involves using both hands together. It is designed for children with mild to moderate hemiparesis who can move their wrist and fingers, attend school full-time, and participate in group activities. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance therapeutic options for children with hemiparesis.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that Modified Constraint Induced Movement Therapy (mCIMT) has been tested for safety and effectiveness in children with cerebral palsy. Studies have found that children generally tolerate this therapy well. For example, one study reported that participants experienced no major side effects. Another study indicated that mCIMT can improve movement skills without causing harm.

Modified Constraint Induced Movement Therapy is unique because it combines two techniques: Constraint Induced Movement Therapy and Bimanual Therapy. Unlike traditional treatments for cerebral palsy, which often focus solely on improving movement in one hand or limb, this therapy encourages the use of both hands together, promoting more balanced motor skills. Researchers are excited about this approach because it aims to enhance overall functionality and independence in children with cerebral palsy, potentially offering more comprehensive benefits than current single-method therapies.

Research has shown that modified constraint-induced movement therapy (mCIMT) can help children with cerebral palsy improve the use of their affected arm. One study found that this therapy significantly enhanced hand and motor skills. Another study demonstrated that children using mCIMT achieved better results than those receiving less intensive traditional therapies. This trial will evaluate mCIMT, which increases the natural use of the affected arm during activities requiring both hands. Additionally, longer therapy sessions may prove even more beneficial for children over five years old. Overall, mCIMT appears promising for improving arm function in children with weakness on one side of the body.¹²³⁶⁷